Zoekresultaten - 2 results

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

confidence interval [CI]: 0.99-1.03) and 1.02 (95%  CI: 1.0-1.04), respectively. Noninferiority p values were all ≤0.05, except for CIN3 + in patients ≥30 years. Excellent intra- and interlaboratory ...

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

compared to controls. Pooled participation difference (PD) and 95% confidence interval (CI) for experimental vs. control was 13.2% (95% CI  = 11.0–15.3%) for mail-to-all, 4.4% (95% CI  = 1.2–7.6%) for ...

QR code

QR code for this page URL